Dermatologicals in the US

Dermatologicals in the US

In 2024, dermatologicals is expected to post low retail current value growth in the US, and see a slight slowdown from the growth rate witnessed in 2023. However, at constant 2024 prices, which excludes the impact of inflation, 2024 is expected to post a marginal value decline, which is actually a slight improvement on the decline witnessed in 2023. While pandemic-driven behaviours such as social distancing are no longer impacting dermatologicals, US consumers continue to struggle with high infl...

Euromonitor International's Dermatologicals in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.